CoChat

Prediction of metabolic drug clearance in humans:In vitro–in vivoextrapolationvsallometric scaling

Shiran, M. R., Proctor, N. J., Howgate, E. M., Rowland-Yeo, K., Tucker, G. T., Rostami-Hodjegan, A. · 2006 · Xenobiotica

The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.

Abstract

Previously in vitro–in vivo extrapolation (IVIVE) with the Simcyp Clearance and Interaction Simulator® has been used to predict the clearance of 15 clinically used drugs in humans. The criteria for the selection of the drugs were that they are used as probes for the activity of specific cytochromes P450 (CYPs) or have a single CYP isoform as the major or sole contributor to their metabolism and that they do not exhibit non-linear kinetics in vivo. Where data were available for the clearance of the drugs in at least three animal species, the predictions from IVIVE have now been compared with those based on allometric scaling (AS). Adequate data were available for estimating oral clearance (CLp.o.) in 9 cases (alprazolam, sildenafil, caffeine, clozapine, cyclosporine, dextromethorphan, midazolam, omeprazole and tolbutamide) and intravenous clearance in 6 cases (CLi.v.) (cyclosporine, diclofenac, midazolam, omeprazole, theophylline and tolterodine). AS predictions were based on five different methods: (1) simple allometry (clearance versus body weight); (2) correction for maximum life-span potential (CL × MLP); (3) correction for brain weight (CL × BrW); (4) the use of body surface area; and (5) the rule of exponents. A prediction accuracy was indicated by mean-fold error and the Pearson product moment correlation coefficient. Predictions were considered successful if the mean-fold error was ≤2. IVIVE predictions were accurate in 14 of 15 cases (mean-fold error range: 1.02–4.00). All five AS methods were accurate in 13, 11, 10, 10 and 14 cases, respectively. However, in some cases the error of AS exceeded fivefold. On the basis of the current results, IVIVE is more reliable than AS in predicting human clearance values for drugs mainly metabolized by CYP450 enzymes. This suggests that the place of AS methods in pre-clinical drug development warrants further scrutiny.

Overview

Integrity signals

Registry

Crossref · 10.1080/00498250600761662

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 123 references

Research works printed but not linked: 18

  1. Amchin J, 1998, Psychopharmacology Bulletin, 34, 211
  2. Bae HY, 2002, Research Communications in Molecular Pathology and Pharmacology, 111, 237
  3. Hamaoka N, 1999, Clinical Pharmacology and Therapy, 66, 110, 10.1053/cp.1999.v66.100038001 · doi:10.1053/cp.1999.v66.100038001 · Paper page
  4. Ibrahim A, 2002, Anesthesia and Analgesics, 95, 667, 10.1213/00000539-200209000-00032 · doi:10.1213/00000539-200209000-00032
  5. Johnson TN, 2006, Clinical Pharmacokinetics (in press)
  6. Karam WG, 1996, Drug Metabolism and Disposition, 24, 1081
  7. Keldenich J, 2004, Technologies, 1, 389
  8. Knodell RG, 1987, Journal of Pharmacology and Experimental Therapy, 241, 1112
  9. Linnet K, 1997, Drug Metabolism and Disposition, 25, 1379
  10. Pahlman I, 2001, Arzneimittelforschung, 51, 134
  11. Postlind H, 1998, Drug Metabolism and Disposition, 26, 289
  12. Rane A, 1977, Journal of Pharmacology and Experimental Therapy, 200, 420
  13. Sangalli L, 1988, Drug Metabolism and Disposition, 16, 749
  14. Tantcheva-Poor I, 1999, Pharmacogenetics, 9, 131
  15. Tsunoda SM, 2001, Clinical Pharmacology and Therapy, 70, 462, 10.1016/S0009-9236(01)70992-7 · doi:10.1016/s0009-9236(01)70992-7
  16. Watanabe K, 2002, Acta Medica Okayama, 56, 19
  17. Yu A, 2001, Drug Metabolism and Disposition, 29, 1362
  18. Zeng YL, 1986, Yao Xue Xue Bao, 21, 566

Cited by

See all 89

Metadata

Authors
Shiran, M. R., Proctor, N. J., Howgate, E. M., Rowland-Yeo, K., Tucker, G. T., & Rostami-Hodjegan, A.
Affiliations
  • Simcyp (United Kingdom) (GB)
  • Royal Hallamshire Hospital (GB)
Venue
Xenobiotica
Published
2006-07
Volume
36
Issue
7
Pages
567-580
ISSN
  • 0049-8254 (ISSN-L)
  • 1366-5928
OpenAlex
W2158185292
Cited by
89
References
122
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 10
FWCI
7.33
Type
journal article
Language
en
Open access
closed
Locations
  • Xenobiotica (publishedVersion)
  • PubMed (publishedVersion)
Funders
Dr Hadwen Trust for Humane Research
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
in vitro-in vivo extrapolation, allometric scaling, cytochrome P450, oral clearance, body surface area, preclinical drug development, alprazolam, sildenafil, caffeine, clozapine, cyclosporine, dextromethorphan, midazolam, omeprazole, tolbutamide, diclofenac, theophylline, tolterodine
MeSH terms
Animals, Dogs, Drug Evaluation, Preclinical, Pharmaceutical Preparations, Humans, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prediction of metabolic drug clearance in humans:In vitro–in vivoextrapolationvsallometric scaling. https://app.cochat.ai/papers/10.1080/00498250600761662
The paper
Shiran, M. R., Proctor, N. J., Howgate, E. M., Rowland-Yeo, K., Tucker, G. T., & Rostami-Hodjegan, A. (2006). Prediction of metabolic drug clearance in humans:In vitro–in vivoextrapolationvsallometric scaling. Xenobiotica. https://doi.org/10.1080/00498250600761662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.